» Articles » PMID: 34434964

RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation

Overview
Specialty Biology
Date 2021 Aug 26
PMID 34434964
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

RUNX1 is a Runt family transcription factor that plays a critical role in normal hematopoiesis, including the differentiation and proliferation of hematopoietic cells. RUNX1 mutations, including chromosomal translocations, cause abnormal cell differentiation, but the mutation alone is not sufficient to cause leukemia. In MLL-fusion-induced leukemia, dysregulated wild-type RUNX1 can promote leukemia survival. Nevertheless, the underlying mechanisms of dysregulated wild-type RUNX1 in leukemia development have not been fully elucidated. This study overexpressed and knocked down RUNX1 expression in THP-1 human leukemia cells and CD34 hematopoietic stem/progenitor cells to investigate the biological functions affected by dysregulated RUNX1. Our data indicated RUNX1 facilitated proliferation to promote leukemia cell growth. Furthermore, we demonstrated that RUNX1 knockdown in leukemia cells drastically diminished colony-forming ability. Finally, the RUNX1-knocked down cell depletion phenotype could be rescued by overexpression of CENPE, a cell proliferation gene and a RUNX1 direct target gene. Our results indicate a possible mechanism involving the RUNX1-CENPE axis on promoting leukemic cell growth.

Citing Articles

MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing RUNX1 transcription.

Liang Y, Wei X, Yue P, Zhang H, Li Z, Wang X Cell Mol Biol Lett. 2024; 29(1):5.

PMID: 38172714 PMC: 10763471. DOI: 10.1186/s11658-023-00522-0.


AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjects.

Gayatri M, Kancha R, Behera A, Patchva D, Velugonda N, Gundeti S Cell Death Discov. 2023; 9(1):401.

PMID: 37903788 PMC: 10616083. DOI: 10.1038/s41420-023-01700-x.


RUNX1-Regulated Signaling Pathways in Ovarian Cancer.

Chen Y, He Y, Liu S Biomedicines. 2023; 11(9).

PMID: 37760803 PMC: 10525517. DOI: 10.3390/biomedicines11092357.


Analysis of Programmed Cell Death-1 (PD-1) Gene Variations (re11568821 and rs41386349) in HTLV-1 Infection Using One Primer Pair and Proviral Load.

Hezave Y, Sharifi Z, Kermani F J Mol Evol. 2023; 91(4):562-566.

PMID: 37020064 DOI: 10.1007/s00239-023-10104-5.

References
1.
Becker H, Pfeifer D, Afonso J, Nimer S, Veelken H, Schwabe M . Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesis. Leukemia. 2008; 22(9):1792-4. DOI: 10.1038/leu.2008.61. View

2.
Wognum B, Yuan N, Lai B, Miller C . Colony forming cell assays for human hematopoietic progenitor cells. Methods Mol Biol. 2012; 946:267-83. DOI: 10.1007/978-1-62703-128-8_17. View

3.
Congrains A, Bianco J, Rosa R, Mancuso R, Saad S . 3D Scaffolds to Model the Hematopoietic Stem Cell Niche: Applications and Perspectives. Materials (Basel). 2021; 14(3). PMC: 7865713. DOI: 10.3390/ma14030569. View

4.
Wilkinson A, Ballabio E, Geng H, North P, Tapia M, Kerry J . RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction. Cell Rep. 2013; 3(1):116-27. PMC: 3607232. DOI: 10.1016/j.celrep.2012.12.016. View

5.
Abrieu A, Kahana J, Wood K, Cleveland D . CENP-E as an essential component of the mitotic checkpoint in vitro. Cell. 2000; 102(6):817-26. DOI: 10.1016/s0092-8674(00)00070-2. View